Commonwealth Equity Services’s Yarrow Bioscience YARW Stock Holding History

Commonwealth Equity Services’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9K	Hold	366	–	–	﹤0.01%	4395
2026 Q1	$10.9K	Hold	366	–	–	﹤0.01%	4277
2025 Q4	$10.6K	Hold	366	–	–	﹤0.01%	4262
2025 Q3	$6K	Hold	366	–	–	﹤0.01%	4229
2025 Q2	$30K	Hold	366	–	–	﹤0.01%	4201
2025 Q1	$29K	Hold	366	–	–	﹤0.01%	4107
2024 Q4	$61K	Hold	366	–	–	﹤0.01%	3969
2024 Q3	$34K	Buy	+366	New	+$34.7K	﹤0.01%	3966
2022 Q1	–	Sell	-22	Closed	-$20K	–	3809
2021 Q4	$20K	Hold	22	–	–	﹤0.01%	3601
2021 Q3	$27K	Buy	22 +1	+5%	+$1.94K	﹤0.01%	3535
2021 Q2	$65K	Hold	21	–	–	﹤0.01%	3443
2021 Q1	$127K	Hold	21	–	–	﹤0.01%	3233
2020 Q4	$122K	Sell	21 -8	-28%	-$50.3K	﹤0.01%	3033
2020 Q3	$172K	Hold	29	–	–	﹤0.01%	2774
2020 Q2	$179K	Buy	29 +1	+4%	+$6.77K	﹤0.01%	2643
2020 Q1	$265K	Buy	28 +1	+4%	+$15.7K	﹤0.01%	2156
2019 Q4	$450K	Buy	+27	New	+$450K	﹤0.01%	2000

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Commonwealth Equity Services's YARW Position: Q2 2026 in Review

Commonwealth Equity Services held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 366 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4395.

Commonwealth Equity Services first reported a position in YARW in Q4 2019 and has held it in 17 quarters since. The position peaked at $450K in Q4 2019. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

Commonwealth Equity Services held 366 shares of Yarrow Bioscience worth $11.9K as of Q2 2026.
Commonwealth Equity Services left its Yarrow Bioscience share count unchanged in Q2 2026.
Yarrow Bioscience made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4395 holding.
Commonwealth Equity Services first reported a position in Yarrow Bioscience in Q4 2019 and has held it in 17 quarters since.
Commonwealth Equity Services's Yarrow Bioscience position peaked at $450K in Q4 2019.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.